ArticleBMC pharmacology & toxicology2013

Raltegravir does not revert efflux activity of MDR1-P-glycoprotein in human MDR cells.

Maria Luisa Dupuis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.